TherapeuticsMD
TXMD
TXMD
53 hedge funds and large institutions have $200M invested in TherapeuticsMD in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
22
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$8.08M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.47M |
| 4 |
BC
Broadfin Capital
New York
|
+$6.24M |
| 5 |
DM
Deerfield Management
New York
|
+$3.66M |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$944K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$378K |
| 3 |
Goldman Sachs
New York
|
-$355K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$339K |
| 5 |
Morgan Stanley
New York
|
-$189K |
